Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-02-21 @ 9:28 AM
Study NCT ID:
NCT06440005
Status:
RECRUITING
Last Update Posted:
2025-06-05
First Post:
2024-05-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Sponsor:
Angiex, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cancer | View |
| None | Advanced Cancer | View |
| None | Locally Advanced Carcinoma | View |
| None | Metastatic Solid Tumor | View |
| None | Breast Cancer | View |
| None | Prostate Cancer | View |
| None | Colorectal Cancer | View |
| None | Pancreatic Cancer | View |
| None | Liver Cancer | View |
| None | Angiosarcoma | View |
| None | Solid Tumor | View |